Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease

Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Background: Bile acids (BAs) are synthesized by the liver and modified by gut bacteria, and may play an intermediary role between the gut microbiome and liver in promoting fibrosis in non-alcoholic fatty liver disease (NAFL...

Full description

Bibliographic Details
Main Authors: Adams, L.A., Wang, Z., Liddle, C., Melton, Phillip E., Ariff, A., Chandraratna, H., Tan, J., Ching, H., Coulter, S., de Boer, B., Christophersen, Claus, O’Sullivan, T.A., Morrison, M., Jeffrey, G.P.
Format: Journal Article
Language:English
Published: WILEY 2020
Subjects:
Science & Technology
Life Sciences & Biomedicine
Gastroenterology & Hepatology
deoxycholic acid
diet
fibrosis
microbiome
non-alcoholic steatohepatitis
FARNESOID X RECEPTOR
STEATOHEPATITIS
INFLAMMATION
MODULATION
MECHANISM
PROFILE
NASH
TERM
Online Access:http://hdl.handle.net/20.500.11937/79136

Internet

http://hdl.handle.net/20.500.11937/79136

Similar Items